Biogen
BIIB
#682
Rank
$27.93 B
Marketcap
$192.20
Share price
0.88%
Change (1 day)
-34.59%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

P/S ratio for Biogen (BIIB)

P/S ratio as of April 2024 (TTM): 2.82

According to Biogen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.81571. At the end of 2023 the company had a P/S ratio of 3.81.

P/S ratio history for Biogen from 2004 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20233.81-2.74%
20223.9222.14%
20213.2114.51%
20202.80-22.05%
20193.60-18.5%
20184.41-19.64%
20175.491.85%
20165.39-13.38%
20156.22-24.18%
20148.21-13.91%
20139.5375.42%
20125.43-2.81%
20115.5963.48%
20103.421.79%
20093.360.33%
20083.35-36.91%
20075.31-40.09%
20068.86-1.23%
20058.97-36.76%
200414.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.78 34.09%๐Ÿ‡บ๐Ÿ‡ธ USA
2.46-12.71%๐Ÿ‡บ๐Ÿ‡ธ USA
5.37 90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
5.00 77.40%๐Ÿ‡บ๐Ÿ‡ธ USA
2.25-20.09%๐Ÿ‡ซ๐Ÿ‡ท France
3.04 8.06%๐Ÿ‡บ๐Ÿ‡ธ USA
4.13 46.53%๐Ÿ‡บ๐Ÿ‡ธ USA
0.0070-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
4.45 57.89%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
3.09 9.67%๐Ÿ‡บ๐Ÿ‡ธ USA